Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients

The ectodomain of gp41 is the target of potent binding and neutralizing antibodies (NAbs) and is being explored in new strategies for antibody-based HIV vaccines. Previous studies have suggested that the W164A-3S (3S) and EC26-2A4 (EC26) peptides located in the gp41 ectodomain may be potential HIV v...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcelino, Rute, Gramacho, Filipa, Martin, Francisco, Brogueira, Pedro, Janeiro, Nuno, Afonso, Claudia, Badura, Robert, Valadas, Emília, Mansinho, Kamal, Caldeira, Luís, Taveira, Nuno, Marcelino, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076315/
https://www.ncbi.nlm.nih.gov/pubmed/33903642
http://dx.doi.org/10.1038/s41598-021-88274-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076315/
https://www.ncbi.nlm.nih.gov/pubmed/33903642
http://dx.doi.org/10.1038/s41598-021-88274-9

Ejemplares similares